Detailed answers about ESME PHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was ESME PHARMA LIMITED founded?
ESME PHARMA LIMITED was officially incorporated on 25 August 2016 and is registered under company number 10346210. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ESME PHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ESME PHARMA LIMITED?
ESME PHARMA LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ESME PHARMA LIMITED do?
ESME PHARMA LIMITED operates in the following sectors: 68100 - Buying and selling of own real estate, 68209 - Other letting and operating of own or leased real estate. These SIC codes provide insight into the company's business activities and industry focus.
What is ESME PHARMA LIMITED's registered address?
The registered office address of ESME PHARMA LIMITED is 124 CITY ROAD, LONDON, ENGLAND, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is ESME PHARMA LIMITED financially stable?
The most recent accounts for ESME PHARMA LIMITED were made up to 31 August 2025, filed as MICRO ENTITY. Next accounts are due by 31 May 2027.
Does ESME PHARMA LIMITED have any charges or mortgages?
ESME PHARMA LIMITED has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.